Arkolith/Insider Trading/CTKB/Form 4

Yan Ming

Chief Technology Officer, DirectorCytek Biosciences, Inc. (CTKB) · full profile →Form 4 · filed Nov 21, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$121K
Net Open-Market Flow
-$121K
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 20, 2023Sell(S)20K$6.03$121K7.8M
Nov 18, 2023Option exercise(M)7K——7.8M
Nov 18, 2023Tax withholding(F)772$5.98$5K7.8M
Nov 18, 2023Tax withholding(F)2K$5.98$15K7.8M
Nov 18, 2023Option exercise(M)2K——7.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 18, 2023Option exercise(M)2K—$017K
Nov 18, 2023Option exercise(M)7K—$098K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-056353) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML